Valuation: CSPC Innovation Pharmaceutical Co., Ltd.

Capitalization 4.57TCr 672.51Cr 573.59Cr 526.05Cr 497.95Cr 922.82Cr 64TCr 931.63Cr 6.27TCr 2.44TCr 31TCr 2.52TCr 2.47TCr 1,06100Cr P/E ratio 2026 *
45.1x
P/E ratio 2027 * 37x
Enterprise value 4.43TCr 651.77Cr 555.89Cr 509.83Cr 482.59Cr 894.36Cr 62TCr 902.9Cr 6.07TCr 2.36TCr 30TCr 2.45TCr 2.39TCr 1,02800Cr EV / Sales 2026 *
10.1x
EV / Sales 2027 * 8.15x
Free-Float
21.43%
Yield 2026 *
0.95%
Yield 2027 * 1.16%
1 day+0.64%
1 week+8.00%
Current month+8.00%
1 month+0.61%
3 months-4.62%
6 months+3.70%
Current year-9.07%
1 week 30.65
Extreme 30.65
33.55
1 month 29.5
Extreme 29.5
34.86
Current year 27.7
Extreme 27.7
47.92
1 year 27.7
Extreme 27.7
63.31
3 years 9.09
Extreme 9.0917
63.31
5 years 5.36
Extreme 5.3611
63.31
10 years 4.98
Extreme 4.979
63.31
Manager TitleAgeSince
Chief Executive Officer 49 22/04/2024
Director of Finance/CFO 34 07/04/2023
Corporate Officer/Principal 42 19/03/2025
Director TitleAgeSince
Director/Board Member 66 15/05/2024
Chairman 50 01/01/2016
Director/Board Member 52 01/01/2016
Change 5d. change 1-year change 3-years change Capi.($)
+0.64%+8.00%-17.59%+205.35% 672.51Cr
+2.45%-3.74%+52.00%+103.65% 1.51TCr
-1.77%+0.48%-5.72%-53.95% 260.2Cr
-0.92%+0.23% - - 152.95Cr
-1.30%+4.54%-5.47%-19.53% 142.79Cr
+0.89%-16.17%+93.06%-2.85% 141.3Cr
+0.85%-10.82%-85.45%-73.94% 110.23Cr
+0.32%+2.32%+1.56%+7.43% 104.08Cr
-0.26%-11.27%-68.46%-71.32% 102.61Cr
-1.35%-2.67%-12.05%-9.88% 91Cr
Average -0.04%-2.78%-5.35%+9.44% 329.19Cr
Weighted average by Cap. +1.05%-0.57%+19.25%+83.54%

Financials

2026 *2027 *
Net sales 437.41Cr 64Cr 55Cr 50Cr 48Cr 88Cr 6.16TCr 89Cr 599.98Cr 233.65Cr 2.92TCr 241.66Cr 236.56Cr 10TCr 527.24Cr 78Cr 66Cr 61Cr 57Cr 106.52Cr 7.43TCr 107.54Cr 723.19Cr 281.63Cr 3.52TCr 291.28Cr 285.14Cr 12TCr
Net income 113.1Cr 17Cr 14Cr 13Cr 12Cr 23Cr 1.59TCr 23Cr 155.14Cr 60Cr 756.02Cr 62Cr 61Cr 2.63TCr 137.81Cr 20Cr 17Cr 16Cr 15Cr 28Cr 1.94TCr 28Cr 189.04Cr 74Cr 921.19Cr 76Cr 75Cr 3.2TCr
Net Debt -140.89Cr -21Cr -18Cr -16Cr -15Cr -28Cr -1.99TCr -29Cr -193.25Cr -75Cr -941.71Cr -78Cr -76Cr -3.27TCr -269.41Cr -40Cr -34Cr -31Cr -29Cr -54Cr -3.8TCr -55Cr -369.55Cr -143.91Cr -1.8TCr -148.84Cr -145.71Cr -6.26TCr
Logo CSPC Innovation Pharmaceutical Co., Ltd.
CSPC Innovation Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of functional ingredients. The Company operates two segments. Functional Ingredients segment mainly provides caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, theophylline, theobromine, pentoxifylline, doxofylline, and biological enzymes. Health Food Products segment mainly provides Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, and others. The Company mainly conducts businesses within the domestic market.
Employees
2,369
Date Price Change Volume
12/26/12 32.80 ¥ +0.64% 1,22,32,570
11/26/11 32.59 ¥ +1.62% 95,64,066
08/26/08 32.07 ¥ -0.16% 1,00,86,480
07/26/07 32.12 ¥ +4.15% 1,17,40,260
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
32.80CNY
Average target price
49.13CNY
Spread / Average Target
+49.80%

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300765 Stock